The Imaging Probe Development Center: An NIH roadmap initiative to promote molecular imaging applications in interdisciplinary research

NUCL 78

Haitao Li, lih3@mail.nih.gov, G. Kaur, Z. Shi, A. Sulima, B. Teng, O. Vasalatiy, H. Wu, B. Xu, S. Cofiell, N. Neale, B. Ruddy, C. Wilson, and G. L. Griffiths. Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD 20850
The NIH Imaging Probe Development Center (IPDC), part of the NIH Roadmap initiatives (www.nihroadmap.nih.gov), is a new synthetic chemistry resource dedicated to research and development of molecular imaging probes. IPDC has been established with the realization that molecular imaging is becoming a key biomedical research technology. IPDC became fully operational in January 2007 with a diverse team of synthetic chemists now working in newly refurbished state-of-the-art equipped facilities located in Rockville, Maryland. Imaging probes produced at the IPDC encompass optical, radioactive and magnetic resonance modalities. Currently, IDPC's services are being provided to the NIH intramural community, but are ultimately intended for collaborative use by the wider, both academic and commercial scientific communities. Ongoing imaging probe development endeavors include but are not restricted to: • Nanosized MRI and fluorescent agents for cancer imaging; • Dextrin and biotin conjugated MRI agents for brain circuitry studies; • Fluorescent nucleotides for DNA/RNA labeling.
 

Sci-Mix
8:00 PM-10:00 PM, Monday, August 20, 2007 BCEC -- Exhibit Hall - B2, Sci-Mix

Division of Nuclear Chemistry & Technology

The 234th ACS National Meeting, Boston, MA, August 19-23, 2007